Global Neurological Disease Model Chip Market Research Report 2024(Status and Outlook)
Report Overview
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The global Neurological Disease Model Chip market size was estimated at USD 50.70 million in 2023 and is projected to reach USD 87.46 million by 2030, exhibiting a CAGR of 8.10% during the forecast period.
North America Neurological Disease Model Chip market size was USD 13.21 million in 2023, at a CAGR of 6.94% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Neurological Disease Model Chip market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurological Disease Model Chip Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurological Disease Model Chip market in any manner.
Global Neurological Disease Model Chip Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Market Segmentation (by Type)
Neuron Chip
Brain Chip
Brain Organ Chip
Market Segmentation (by Application)
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Disease Model Chip Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The global Neurological Disease Model Chip market size was estimated at USD 50.70 million in 2023 and is projected to reach USD 87.46 million by 2030, exhibiting a CAGR of 8.10% during the forecast period.
North America Neurological Disease Model Chip market size was USD 13.21 million in 2023, at a CAGR of 6.94% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Neurological Disease Model Chip market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurological Disease Model Chip Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurological Disease Model Chip market in any manner.
Global Neurological Disease Model Chip Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Market Segmentation (by Type)
Neuron Chip
Brain Chip
Brain Organ Chip
Market Segmentation (by Application)
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neurological Disease Model Chip Market
- Overview of the regional outlook of the Neurological Disease Model Chip Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Disease Model Chip Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neurological Disease Model Chip
1.2 Key Market Segments
1.2.1 Neurological Disease Model Chip Segment by Type
1.2.2 Neurological Disease Model Chip Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGICAL DISEASE MODEL CHIP MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurological Disease Model Chip Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurological Disease Model Chip Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGICAL DISEASE MODEL CHIP MARKET COMPETITIVE LANDSCAPE
3.1 Global Neurological Disease Model Chip Sales by Manufacturers (2019-2024)
3.2 Global Neurological Disease Model Chip Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurological Disease Model Chip Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurological Disease Model Chip Sales Sites, Area Served, Product Type
3.6 Neurological Disease Model Chip Market Competitive Situation and Trends
3.6.1 Neurological Disease Model Chip Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurological Disease Model Chip Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL DISEASE MODEL CHIP INDUSTRY CHAIN ANALYSIS
4.1 Neurological Disease Model Chip Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGICAL DISEASE MODEL CHIP MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
6.3 Global Neurological Disease Model Chip Market Size Market Share by Type (2019-2024)
6.4 Global Neurological Disease Model Chip Price by Type (2019-2024)
7 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Disease Model Chip Market Sales by Application (2019-2024)
7.3 Global Neurological Disease Model Chip Market Size (M USD) by Application (2019-2024)
7.4 Global Neurological Disease Model Chip Sales Growth Rate by Application (2019-2024)
8 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY REGION
8.1 Global Neurological Disease Model Chip Sales by Region
8.1.1 Global Neurological Disease Model Chip Sales by Region
8.1.2 Global Neurological Disease Model Chip Sales Market Share by Region
8.2 North America
8.2.1 North America Neurological Disease Model Chip Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurological Disease Model Chip Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurological Disease Model Chip Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurological Disease Model Chip Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurological Disease Model Chip Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Emulate
9.1.1 Emulate Neurological Disease Model Chip Basic Information
9.1.2 Emulate Neurological Disease Model Chip Product Overview
9.1.3 Emulate Neurological Disease Model Chip Product Market Performance
9.1.4 Emulate Business Overview
9.1.5 Emulate Neurological Disease Model Chip SWOT Analysis
9.1.6 Emulate Recent Developments
9.2 CN Bio
9.2.1 CN Bio Neurological Disease Model Chip Basic Information
9.2.2 CN Bio Neurological Disease Model Chip Product Overview
9.2.3 CN Bio Neurological Disease Model Chip Product Market Performance
9.2.4 CN Bio Business Overview
9.2.5 CN Bio Neurological Disease Model Chip SWOT Analysis
9.2.6 CN Bio Recent Developments
9.3 TissUse
9.3.1 TissUse Neurological Disease Model Chip Basic Information
9.3.2 TissUse Neurological Disease Model Chip Product Overview
9.3.3 TissUse Neurological Disease Model Chip Product Market Performance
9.3.4 TissUse Neurological Disease Model Chip SWOT Analysis
9.3.5 TissUse Business Overview
9.3.6 TissUse Recent Developments
9.4 AxoSim Technologies
9.4.1 AxoSim Technologies Neurological Disease Model Chip Basic Information
9.4.2 AxoSim Technologies Neurological Disease Model Chip Product Overview
9.4.3 AxoSim Technologies Neurological Disease Model Chip Product Market Performance
9.4.4 AxoSim Technologies Business Overview
9.4.5 AxoSim Technologies Recent Developments
9.5 Nortis
9.5.1 Nortis Neurological Disease Model Chip Basic Information
9.5.2 Nortis Neurological Disease Model Chip Product Overview
9.5.3 Nortis Neurological Disease Model Chip Product Market Performance
9.5.4 Nortis Business Overview
9.5.5 Nortis Recent Developments
9.6 Mimetas
9.6.1 Mimetas Neurological Disease Model Chip Basic Information
9.6.2 Mimetas Neurological Disease Model Chip Product Overview
9.6.3 Mimetas Neurological Disease Model Chip Product Market Performance
9.6.4 Mimetas Business Overview
9.6.5 Mimetas Recent Developments
9.7 SynVivo
9.7.1 SynVivo Neurological Disease Model Chip Basic Information
9.7.2 SynVivo Neurological Disease Model Chip Product Overview
9.7.3 SynVivo Neurological Disease Model Chip Product Market Performance
9.7.4 SynVivo Business Overview
9.7.5 SynVivo Recent Developments
9.8 Axion Biosystems
9.8.1 Axion Biosystems Neurological Disease Model Chip Basic Information
9.8.2 Axion Biosystems Neurological Disease Model Chip Product Overview
9.8.3 Axion Biosystems Neurological Disease Model Chip Product Market Performance
9.8.4 Axion Biosystems Business Overview
9.8.5 Axion Biosystems Recent Developments
9.9 Tara Biosystems
9.9.1 Tara Biosystems Neurological Disease Model Chip Basic Information
9.9.2 Tara Biosystems Neurological Disease Model Chip Product Overview
9.9.3 Tara Biosystems Neurological Disease Model Chip Product Market Performance
9.9.4 Tara Biosystems Business Overview
9.9.5 Tara Biosystems Recent Developments
9.10 InSphero
9.10.1 InSphero Neurological Disease Model Chip Basic Information
9.10.2 InSphero Neurological Disease Model Chip Product Overview
9.10.3 InSphero Neurological Disease Model Chip Product Market Performance
9.10.4 InSphero Business Overview
9.10.5 InSphero Recent Developments
9.11 Hesperos
9.11.1 Hesperos Neurological Disease Model Chip Basic Information
9.11.2 Hesperos Neurological Disease Model Chip Product Overview
9.11.3 Hesperos Neurological Disease Model Chip Product Market Performance
9.11.4 Hesperos Business Overview
9.11.5 Hesperos Recent Developments
9.12 Kugelmeiers
9.12.1 Kugelmeiers Neurological Disease Model Chip Basic Information
9.12.2 Kugelmeiers Neurological Disease Model Chip Product Overview
9.12.3 Kugelmeiers Neurological Disease Model Chip Product Market Performance
9.12.4 Kugelmeiers Business Overview
9.12.5 Kugelmeiers Recent Developments
9.13 Ascendance Biotechnology
9.13.1 Ascendance Biotechnology Neurological Disease Model Chip Basic Information
9.13.2 Ascendance Biotechnology Neurological Disease Model Chip Product Overview
9.13.3 Ascendance Biotechnology Neurological Disease Model Chip Product Market Performance
9.13.4 Ascendance Biotechnology Business Overview
9.13.5 Ascendance Biotechnology Recent Developments
9.14 BioIVT
9.14.1 BioIVT Neurological Disease Model Chip Basic Information
9.14.2 BioIVT Neurological Disease Model Chip Product Overview
9.14.3 BioIVT Neurological Disease Model Chip Product Market Performance
9.14.4 BioIVT Business Overview
9.14.5 BioIVT Recent Developments
9.15 BGI Genomics
9.15.1 BGI Genomics Neurological Disease Model Chip Basic Information
9.15.2 BGI Genomics Neurological Disease Model Chip Product Overview
9.15.3 BGI Genomics Neurological Disease Model Chip Product Market Performance
9.15.4 BGI Genomics Business Overview
9.15.5 BGI Genomics Recent Developments
10 NEUROLOGICAL DISEASE MODEL CHIP MARKET FORECAST BY REGION
10.1 Global Neurological Disease Model Chip Market Size Forecast
10.2 Global Neurological Disease Model Chip Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurological Disease Model Chip Market Size Forecast by Country
10.2.3 Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region
10.2.4 South America Neurological Disease Model Chip Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurological Disease Model Chip by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neurological Disease Model Chip Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurological Disease Model Chip by Type (2025-2030)
11.1.2 Global Neurological Disease Model Chip Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurological Disease Model Chip by Type (2025-2030)
11.2 Global Neurological Disease Model Chip Market Forecast by Application (2025-2030)
11.2.1 Global Neurological Disease Model Chip Sales (K Units) Forecast by Application
11.2.2 Global Neurological Disease Model Chip Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neurological Disease Model Chip
1.2 Key Market Segments
1.2.1 Neurological Disease Model Chip Segment by Type
1.2.2 Neurological Disease Model Chip Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGICAL DISEASE MODEL CHIP MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurological Disease Model Chip Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurological Disease Model Chip Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGICAL DISEASE MODEL CHIP MARKET COMPETITIVE LANDSCAPE
3.1 Global Neurological Disease Model Chip Sales by Manufacturers (2019-2024)
3.2 Global Neurological Disease Model Chip Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurological Disease Model Chip Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurological Disease Model Chip Sales Sites, Area Served, Product Type
3.6 Neurological Disease Model Chip Market Competitive Situation and Trends
3.6.1 Neurological Disease Model Chip Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurological Disease Model Chip Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL DISEASE MODEL CHIP INDUSTRY CHAIN ANALYSIS
4.1 Neurological Disease Model Chip Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGICAL DISEASE MODEL CHIP MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
6.3 Global Neurological Disease Model Chip Market Size Market Share by Type (2019-2024)
6.4 Global Neurological Disease Model Chip Price by Type (2019-2024)
7 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Disease Model Chip Market Sales by Application (2019-2024)
7.3 Global Neurological Disease Model Chip Market Size (M USD) by Application (2019-2024)
7.4 Global Neurological Disease Model Chip Sales Growth Rate by Application (2019-2024)
8 NEUROLOGICAL DISEASE MODEL CHIP MARKET SEGMENTATION BY REGION
8.1 Global Neurological Disease Model Chip Sales by Region
8.1.1 Global Neurological Disease Model Chip Sales by Region
8.1.2 Global Neurological Disease Model Chip Sales Market Share by Region
8.2 North America
8.2.1 North America Neurological Disease Model Chip Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurological Disease Model Chip Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurological Disease Model Chip Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurological Disease Model Chip Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurological Disease Model Chip Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Emulate
9.1.1 Emulate Neurological Disease Model Chip Basic Information
9.1.2 Emulate Neurological Disease Model Chip Product Overview
9.1.3 Emulate Neurological Disease Model Chip Product Market Performance
9.1.4 Emulate Business Overview
9.1.5 Emulate Neurological Disease Model Chip SWOT Analysis
9.1.6 Emulate Recent Developments
9.2 CN Bio
9.2.1 CN Bio Neurological Disease Model Chip Basic Information
9.2.2 CN Bio Neurological Disease Model Chip Product Overview
9.2.3 CN Bio Neurological Disease Model Chip Product Market Performance
9.2.4 CN Bio Business Overview
9.2.5 CN Bio Neurological Disease Model Chip SWOT Analysis
9.2.6 CN Bio Recent Developments
9.3 TissUse
9.3.1 TissUse Neurological Disease Model Chip Basic Information
9.3.2 TissUse Neurological Disease Model Chip Product Overview
9.3.3 TissUse Neurological Disease Model Chip Product Market Performance
9.3.4 TissUse Neurological Disease Model Chip SWOT Analysis
9.3.5 TissUse Business Overview
9.3.6 TissUse Recent Developments
9.4 AxoSim Technologies
9.4.1 AxoSim Technologies Neurological Disease Model Chip Basic Information
9.4.2 AxoSim Technologies Neurological Disease Model Chip Product Overview
9.4.3 AxoSim Technologies Neurological Disease Model Chip Product Market Performance
9.4.4 AxoSim Technologies Business Overview
9.4.5 AxoSim Technologies Recent Developments
9.5 Nortis
9.5.1 Nortis Neurological Disease Model Chip Basic Information
9.5.2 Nortis Neurological Disease Model Chip Product Overview
9.5.3 Nortis Neurological Disease Model Chip Product Market Performance
9.5.4 Nortis Business Overview
9.5.5 Nortis Recent Developments
9.6 Mimetas
9.6.1 Mimetas Neurological Disease Model Chip Basic Information
9.6.2 Mimetas Neurological Disease Model Chip Product Overview
9.6.3 Mimetas Neurological Disease Model Chip Product Market Performance
9.6.4 Mimetas Business Overview
9.6.5 Mimetas Recent Developments
9.7 SynVivo
9.7.1 SynVivo Neurological Disease Model Chip Basic Information
9.7.2 SynVivo Neurological Disease Model Chip Product Overview
9.7.3 SynVivo Neurological Disease Model Chip Product Market Performance
9.7.4 SynVivo Business Overview
9.7.5 SynVivo Recent Developments
9.8 Axion Biosystems
9.8.1 Axion Biosystems Neurological Disease Model Chip Basic Information
9.8.2 Axion Biosystems Neurological Disease Model Chip Product Overview
9.8.3 Axion Biosystems Neurological Disease Model Chip Product Market Performance
9.8.4 Axion Biosystems Business Overview
9.8.5 Axion Biosystems Recent Developments
9.9 Tara Biosystems
9.9.1 Tara Biosystems Neurological Disease Model Chip Basic Information
9.9.2 Tara Biosystems Neurological Disease Model Chip Product Overview
9.9.3 Tara Biosystems Neurological Disease Model Chip Product Market Performance
9.9.4 Tara Biosystems Business Overview
9.9.5 Tara Biosystems Recent Developments
9.10 InSphero
9.10.1 InSphero Neurological Disease Model Chip Basic Information
9.10.2 InSphero Neurological Disease Model Chip Product Overview
9.10.3 InSphero Neurological Disease Model Chip Product Market Performance
9.10.4 InSphero Business Overview
9.10.5 InSphero Recent Developments
9.11 Hesperos
9.11.1 Hesperos Neurological Disease Model Chip Basic Information
9.11.2 Hesperos Neurological Disease Model Chip Product Overview
9.11.3 Hesperos Neurological Disease Model Chip Product Market Performance
9.11.4 Hesperos Business Overview
9.11.5 Hesperos Recent Developments
9.12 Kugelmeiers
9.12.1 Kugelmeiers Neurological Disease Model Chip Basic Information
9.12.2 Kugelmeiers Neurological Disease Model Chip Product Overview
9.12.3 Kugelmeiers Neurological Disease Model Chip Product Market Performance
9.12.4 Kugelmeiers Business Overview
9.12.5 Kugelmeiers Recent Developments
9.13 Ascendance Biotechnology
9.13.1 Ascendance Biotechnology Neurological Disease Model Chip Basic Information
9.13.2 Ascendance Biotechnology Neurological Disease Model Chip Product Overview
9.13.3 Ascendance Biotechnology Neurological Disease Model Chip Product Market Performance
9.13.4 Ascendance Biotechnology Business Overview
9.13.5 Ascendance Biotechnology Recent Developments
9.14 BioIVT
9.14.1 BioIVT Neurological Disease Model Chip Basic Information
9.14.2 BioIVT Neurological Disease Model Chip Product Overview
9.14.3 BioIVT Neurological Disease Model Chip Product Market Performance
9.14.4 BioIVT Business Overview
9.14.5 BioIVT Recent Developments
9.15 BGI Genomics
9.15.1 BGI Genomics Neurological Disease Model Chip Basic Information
9.15.2 BGI Genomics Neurological Disease Model Chip Product Overview
9.15.3 BGI Genomics Neurological Disease Model Chip Product Market Performance
9.15.4 BGI Genomics Business Overview
9.15.5 BGI Genomics Recent Developments
10 NEUROLOGICAL DISEASE MODEL CHIP MARKET FORECAST BY REGION
10.1 Global Neurological Disease Model Chip Market Size Forecast
10.2 Global Neurological Disease Model Chip Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurological Disease Model Chip Market Size Forecast by Country
10.2.3 Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region
10.2.4 South America Neurological Disease Model Chip Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurological Disease Model Chip by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neurological Disease Model Chip Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurological Disease Model Chip by Type (2025-2030)
11.1.2 Global Neurological Disease Model Chip Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurological Disease Model Chip by Type (2025-2030)
11.2 Global Neurological Disease Model Chip Market Forecast by Application (2025-2030)
11.2.1 Global Neurological Disease Model Chip Sales (K Units) Forecast by Application
11.2.2 Global Neurological Disease Model Chip Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurological Disease Model Chip Market Size Comparison by Region (M USD)
Table 5. Global Neurological Disease Model Chip Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neurological Disease Model Chip Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neurological Disease Model Chip Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model Chip as of 2022)
Table 10. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neurological Disease Model Chip Sales Sites and Area Served
Table 12. Manufacturers Neurological Disease Model Chip Product Type
Table 13. Global Neurological Disease Model Chip Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurological Disease Model Chip
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurological Disease Model Chip Market Challenges
Table 22. Global Neurological Disease Model Chip Sales by Type (K Units)
Table 23. Global Neurological Disease Model Chip Market Size by Type (M USD)
Table 24. Global Neurological Disease Model Chip Sales (K Units) by Type (2019-2024)
Table 25. Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Table 26. Global Neurological Disease Model Chip Market Size (M USD) by Type (2019-2024)
Table 27. Global Neurological Disease Model Chip Market Size Share by Type (2019-2024)
Table 28. Global Neurological Disease Model Chip Price (USD/Unit) by Type (2019-2024)
Table 29. Global Neurological Disease Model Chip Sales (K Units) by Application
Table 30. Global Neurological Disease Model Chip Market Size by Application
Table 31. Global Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 32. Global Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Table 33. Global Neurological Disease Model Chip Sales by Application (2019-2024) & (M USD)
Table 34. Global Neurological Disease Model Chip Market Share by Application (2019-2024)
Table 35. Global Neurological Disease Model Chip Sales Growth Rate by Application (2019-2024)
Table 36. Global Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 37. Global Neurological Disease Model Chip Sales Market Share by Region (2019-2024)
Table 38. North America Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 39. Europe Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 41. South America Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 43. Emulate Neurological Disease Model Chip Basic Information
Table 44. Emulate Neurological Disease Model Chip Product Overview
Table 45. Emulate Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Emulate Business Overview
Table 47. Emulate Neurological Disease Model Chip SWOT Analysis
Table 48. Emulate Recent Developments
Table 49. CN Bio Neurological Disease Model Chip Basic Information
Table 50. CN Bio Neurological Disease Model Chip Product Overview
Table 51. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. CN Bio Business Overview
Table 53. CN Bio Neurological Disease Model Chip SWOT Analysis
Table 54. CN Bio Recent Developments
Table 55. TissUse Neurological Disease Model Chip Basic Information
Table 56. TissUse Neurological Disease Model Chip Product Overview
Table 57. TissUse Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. TissUse Neurological Disease Model Chip SWOT Analysis
Table 59. TissUse Business Overview
Table 60. TissUse Recent Developments
Table 61. AxoSim Technologies Neurological Disease Model Chip Basic Information
Table 62. AxoSim Technologies Neurological Disease Model Chip Product Overview
Table 63. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AxoSim Technologies Business Overview
Table 65. AxoSim Technologies Recent Developments
Table 66. Nortis Neurological Disease Model Chip Basic Information
Table 67. Nortis Neurological Disease Model Chip Product Overview
Table 68. Nortis Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Nortis Business Overview
Table 70. Nortis Recent Developments
Table 71. Mimetas Neurological Disease Model Chip Basic Information
Table 72. Mimetas Neurological Disease Model Chip Product Overview
Table 73. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mimetas Business Overview
Table 75. Mimetas Recent Developments
Table 76. SynVivo Neurological Disease Model Chip Basic Information
Table 77. SynVivo Neurological Disease Model Chip Product Overview
Table 78. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. SynVivo Business Overview
Table 80. SynVivo Recent Developments
Table 81. Axion Biosystems Neurological Disease Model Chip Basic Information
Table 82. Axion Biosystems Neurological Disease Model Chip Product Overview
Table 83. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Axion Biosystems Business Overview
Table 85. Axion Biosystems Recent Developments
Table 86. Tara Biosystems Neurological Disease Model Chip Basic Information
Table 87. Tara Biosystems Neurological Disease Model Chip Product Overview
Table 88. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Tara Biosystems Business Overview
Table 90. Tara Biosystems Recent Developments
Table 91. InSphero Neurological Disease Model Chip Basic Information
Table 92. InSphero Neurological Disease Model Chip Product Overview
Table 93. InSphero Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. InSphero Business Overview
Table 95. InSphero Recent Developments
Table 96. Hesperos Neurological Disease Model Chip Basic Information
Table 97. Hesperos Neurological Disease Model Chip Product Overview
Table 98. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Hesperos Business Overview
Table 100. Hesperos Recent Developments
Table 101. Kugelmeiers Neurological Disease Model Chip Basic Information
Table 102. Kugelmeiers Neurological Disease Model Chip Product Overview
Table 103. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Kugelmeiers Business Overview
Table 105. Kugelmeiers Recent Developments
Table 106. Ascendance Biotechnology Neurological Disease Model Chip Basic Information
Table 107. Ascendance Biotechnology Neurological Disease Model Chip Product Overview
Table 108. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Ascendance Biotechnology Business Overview
Table 110. Ascendance Biotechnology Recent Developments
Table 111. BioIVT Neurological Disease Model Chip Basic Information
Table 112. BioIVT Neurological Disease Model Chip Product Overview
Table 113. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. BioIVT Business Overview
Table 115. BioIVT Recent Developments
Table 116. BGI Genomics Neurological Disease Model Chip Basic Information
Table 117. BGI Genomics Neurological Disease Model Chip Product Overview
Table 118. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. BGI Genomics Business Overview
Table 120. BGI Genomics Recent Developments
Table 121. Global Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Neurological Disease Model Chip Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Neurological Disease Model Chip Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Neurological Disease Model Chip Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Neurological Disease Model Chip Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Neurological Disease Model Chip Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Neurological Disease Model Chip Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Neurological Disease Model Chip Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurological Disease Model Chip Market Size Comparison by Region (M USD)
Table 5. Global Neurological Disease Model Chip Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neurological Disease Model Chip Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neurological Disease Model Chip Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model Chip as of 2022)
Table 10. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neurological Disease Model Chip Sales Sites and Area Served
Table 12. Manufacturers Neurological Disease Model Chip Product Type
Table 13. Global Neurological Disease Model Chip Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurological Disease Model Chip
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurological Disease Model Chip Market Challenges
Table 22. Global Neurological Disease Model Chip Sales by Type (K Units)
Table 23. Global Neurological Disease Model Chip Market Size by Type (M USD)
Table 24. Global Neurological Disease Model Chip Sales (K Units) by Type (2019-2024)
Table 25. Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Table 26. Global Neurological Disease Model Chip Market Size (M USD) by Type (2019-2024)
Table 27. Global Neurological Disease Model Chip Market Size Share by Type (2019-2024)
Table 28. Global Neurological Disease Model Chip Price (USD/Unit) by Type (2019-2024)
Table 29. Global Neurological Disease Model Chip Sales (K Units) by Application
Table 30. Global Neurological Disease Model Chip Market Size by Application
Table 31. Global Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 32. Global Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Table 33. Global Neurological Disease Model Chip Sales by Application (2019-2024) & (M USD)
Table 34. Global Neurological Disease Model Chip Market Share by Application (2019-2024)
Table 35. Global Neurological Disease Model Chip Sales Growth Rate by Application (2019-2024)
Table 36. Global Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 37. Global Neurological Disease Model Chip Sales Market Share by Region (2019-2024)
Table 38. North America Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 39. Europe Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 41. South America Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 43. Emulate Neurological Disease Model Chip Basic Information
Table 44. Emulate Neurological Disease Model Chip Product Overview
Table 45. Emulate Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Emulate Business Overview
Table 47. Emulate Neurological Disease Model Chip SWOT Analysis
Table 48. Emulate Recent Developments
Table 49. CN Bio Neurological Disease Model Chip Basic Information
Table 50. CN Bio Neurological Disease Model Chip Product Overview
Table 51. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. CN Bio Business Overview
Table 53. CN Bio Neurological Disease Model Chip SWOT Analysis
Table 54. CN Bio Recent Developments
Table 55. TissUse Neurological Disease Model Chip Basic Information
Table 56. TissUse Neurological Disease Model Chip Product Overview
Table 57. TissUse Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. TissUse Neurological Disease Model Chip SWOT Analysis
Table 59. TissUse Business Overview
Table 60. TissUse Recent Developments
Table 61. AxoSim Technologies Neurological Disease Model Chip Basic Information
Table 62. AxoSim Technologies Neurological Disease Model Chip Product Overview
Table 63. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AxoSim Technologies Business Overview
Table 65. AxoSim Technologies Recent Developments
Table 66. Nortis Neurological Disease Model Chip Basic Information
Table 67. Nortis Neurological Disease Model Chip Product Overview
Table 68. Nortis Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Nortis Business Overview
Table 70. Nortis Recent Developments
Table 71. Mimetas Neurological Disease Model Chip Basic Information
Table 72. Mimetas Neurological Disease Model Chip Product Overview
Table 73. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mimetas Business Overview
Table 75. Mimetas Recent Developments
Table 76. SynVivo Neurological Disease Model Chip Basic Information
Table 77. SynVivo Neurological Disease Model Chip Product Overview
Table 78. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. SynVivo Business Overview
Table 80. SynVivo Recent Developments
Table 81. Axion Biosystems Neurological Disease Model Chip Basic Information
Table 82. Axion Biosystems Neurological Disease Model Chip Product Overview
Table 83. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Axion Biosystems Business Overview
Table 85. Axion Biosystems Recent Developments
Table 86. Tara Biosystems Neurological Disease Model Chip Basic Information
Table 87. Tara Biosystems Neurological Disease Model Chip Product Overview
Table 88. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Tara Biosystems Business Overview
Table 90. Tara Biosystems Recent Developments
Table 91. InSphero Neurological Disease Model Chip Basic Information
Table 92. InSphero Neurological Disease Model Chip Product Overview
Table 93. InSphero Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. InSphero Business Overview
Table 95. InSphero Recent Developments
Table 96. Hesperos Neurological Disease Model Chip Basic Information
Table 97. Hesperos Neurological Disease Model Chip Product Overview
Table 98. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Hesperos Business Overview
Table 100. Hesperos Recent Developments
Table 101. Kugelmeiers Neurological Disease Model Chip Basic Information
Table 102. Kugelmeiers Neurological Disease Model Chip Product Overview
Table 103. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Kugelmeiers Business Overview
Table 105. Kugelmeiers Recent Developments
Table 106. Ascendance Biotechnology Neurological Disease Model Chip Basic Information
Table 107. Ascendance Biotechnology Neurological Disease Model Chip Product Overview
Table 108. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Ascendance Biotechnology Business Overview
Table 110. Ascendance Biotechnology Recent Developments
Table 111. BioIVT Neurological Disease Model Chip Basic Information
Table 112. BioIVT Neurological Disease Model Chip Product Overview
Table 113. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. BioIVT Business Overview
Table 115. BioIVT Recent Developments
Table 116. BGI Genomics Neurological Disease Model Chip Basic Information
Table 117. BGI Genomics Neurological Disease Model Chip Product Overview
Table 118. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. BGI Genomics Business Overview
Table 120. BGI Genomics Recent Developments
Table 121. Global Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Neurological Disease Model Chip Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Neurological Disease Model Chip Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Neurological Disease Model Chip Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Neurological Disease Model Chip Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Neurological Disease Model Chip Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Neurological Disease Model Chip Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Neurological Disease Model Chip Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Neurological Disease Model Chip Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Neurological Disease Model Chip Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neurological Disease Model Chip
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurological Disease Model Chip Market Size (M USD), 2019-2030
Figure 5. Global Neurological Disease Model Chip Market Size (M USD) (2019-2030)
Figure 6. Global Neurological Disease Model Chip Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurological Disease Model Chip Market Size by Country (M USD)
Figure 11. Neurological Disease Model Chip Sales Share by Manufacturers in 2023
Figure 12. Global Neurological Disease Model Chip Revenue Share by Manufacturers in 2023
Figure 13. Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurological Disease Model Chip Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurological Disease Model Chip Market Share by Type
Figure 18. Sales Market Share of Neurological Disease Model Chip by Type (2019-2024)
Figure 19. Sales Market Share of Neurological Disease Model Chip by Type in 2023
Figure 20. Market Size Share of Neurological Disease Model Chip by Type (2019-2024)
Figure 21. Market Size Market Share of Neurological Disease Model Chip by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurological Disease Model Chip Market Share by Application
Figure 24. Global Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 25. Global Neurological Disease Model Chip Sales Market Share by Application in 2023
Figure 26. Global Neurological Disease Model Chip Market Share by Application (2019-2024)
Figure 27. Global Neurological Disease Model Chip Market Share by Application in 2023
Figure 28. Global Neurological Disease Model Chip Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neurological Disease Model Chip Sales Market Share by Region (2019-2024)
Figure 30. North America Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 32. U.S. Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Neurological Disease Model Chip Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Neurological Disease Model Chip Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 37. Germany Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Neurological Disease Model Chip Sales Market Share by Region in 2023
Figure 44. China Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 50. South America Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 51. Brazil Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Neurological Disease Model Chip Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Neurological Disease Model Chip Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Neurological Disease Model Chip Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neurological Disease Model Chip Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neurological Disease Model Chip Market Share Forecast by Type (2025-2030)
Figure 65. Global Neurological Disease Model Chip Sales Forecast by Application (2025-2030)
Figure 66. Global Neurological Disease Model Chip Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Neurological Disease Model Chip
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurological Disease Model Chip Market Size (M USD), 2019-2030
Figure 5. Global Neurological Disease Model Chip Market Size (M USD) (2019-2030)
Figure 6. Global Neurological Disease Model Chip Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurological Disease Model Chip Market Size by Country (M USD)
Figure 11. Neurological Disease Model Chip Sales Share by Manufacturers in 2023
Figure 12. Global Neurological Disease Model Chip Revenue Share by Manufacturers in 2023
Figure 13. Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurological Disease Model Chip Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurological Disease Model Chip Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurological Disease Model Chip Market Share by Type
Figure 18. Sales Market Share of Neurological Disease Model Chip by Type (2019-2024)
Figure 19. Sales Market Share of Neurological Disease Model Chip by Type in 2023
Figure 20. Market Size Share of Neurological Disease Model Chip by Type (2019-2024)
Figure 21. Market Size Market Share of Neurological Disease Model Chip by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurological Disease Model Chip Market Share by Application
Figure 24. Global Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 25. Global Neurological Disease Model Chip Sales Market Share by Application in 2023
Figure 26. Global Neurological Disease Model Chip Market Share by Application (2019-2024)
Figure 27. Global Neurological Disease Model Chip Market Share by Application in 2023
Figure 28. Global Neurological Disease Model Chip Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neurological Disease Model Chip Sales Market Share by Region (2019-2024)
Figure 30. North America Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 32. U.S. Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Neurological Disease Model Chip Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Neurological Disease Model Chip Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 37. Germany Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Neurological Disease Model Chip Sales Market Share by Region in 2023
Figure 44. China Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 50. South America Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 51. Brazil Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Neurological Disease Model Chip Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Neurological Disease Model Chip Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Neurological Disease Model Chip Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Neurological Disease Model Chip Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Neurological Disease Model Chip Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neurological Disease Model Chip Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neurological Disease Model Chip Market Share Forecast by Type (2025-2030)
Figure 65. Global Neurological Disease Model Chip Sales Forecast by Application (2025-2030)
Figure 66. Global Neurological Disease Model Chip Market Share Forecast by Application (2025-2030)
